Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
Crossref DOI link: https://doi.org/10.1007/s40257-022-00717-9
Published Online: 2022-08-04
Published Print: 2022-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hoy, Sheridan M.
Text and Data Mining valid from 2022-08-04
Version of Record valid from 2022-08-04
Article History
First Online: 4 August 2022